← Every firm
Fagron, Inc FDA Recalls
10 recalls on file across drugs, 1 of them Class I and 4 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| NYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, InClass IIDec 11, 2023Labeling: Label Error on Declared Strength: Assay value on t |
| NYSTATIN 500 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron,Class IIDec 11, 2023Labeling: Label Error on Declared Strength: Assay value on t |
| NYSTATIN 2 BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, IClass IIDec 11, 2023Labeling: Label Error on Declared Strength: Assay value on t |
| NYSTATIN 150 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron,Class IIDec 11, 2023Labeling: Label Error on Declared Strength: Assay value on t |
| Nandrolone Decanoate, USP, 1 kg per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 740Class IIIMar 4, 2022Subpotent Drug |
| Nandrolone Decanoate, USP, 100 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot KClass IIIMar 4, 2022Subpotent Drug |
| Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot KClass IIIMar 4, 2022Subpotent Drug |
| SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 515Class IMar 4, 2022Microbial Contamination of Non-Sterile Product: Product is c |
| Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 74Class IIIMar 4, 2022Subpotent Drug |
| Nandrolone Decanoate, USP, 1 kg per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot KnClass IIIMar 4, 2022Subpotent Drug |